3527-19-3

Basic information

• Product Name: 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI)
• Synonyms: 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI);1,2-Dimethyl-1H-1,3-benzodiazol-5-amine
• CAS NO: 3527-19-3
• Molecular Formula: C₉H₁₁N₃
• Molecular Weight: 161.20374
• Product Categories: BENZIMIDAZOLE
• Mol File: 3527-19-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 220 °C
• Boiling Point: 377.3±15.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3(Predicted)
• PKA: 6.95±0.25(Predicted)
• CAS DataBase Reference: 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI)(3527-19-3)
• EPA Substance Registry System: 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI)(3527-19-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 3527-19-3(Hazardous Substances Data)

Usage

General Description

The chemical 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI) is a member of the benzimidazole family, which is characterized by a bicyclic structure containing a benzene ring fused to an imidazole ring. It is specifically a derivative of benzimidazole with an amine group at the 5th position and two methyl groups at the 1st and 2nd positions. This chemical is often used as a building block in the synthesis of various pharmaceuticals and agrochemicals due to its versatile reactivity and structural properties. Additionally, it exhibits potential biological activities, such as anti-inflammatory, anti-cancer, and anti-microbial properties, making it a valuable compound for further research and development.

Upstream product

• 49819-79-6 1,2-dimethyl-5-nitro-1H-benzimidazole 
• 1792-40-1 2-methyl-5-nitrobenzimidazole 
• 364-73-8 4-Bromo-1-fluoro-2-nitrobenzene 
• 99513-17-4 5-bromo-1,2-dimethyl-1H-benzo[d]imidazole 
• 69038-76-2 2-N-methylamino-5-bromoaniline 
• 53484-26-7 N-methyl-4-bromo-2-nitroaniline 
• 369-36-8 6-fluoro-3-nitroaniline 
• 615-15-6 2-Methyl-1H-benzimidazole 
• 95-54-5 1,2-diamino-benzene 
• 2876-08-6 1,2-dimethyl-1H-benzimidazole 
• 19492-66-1 1,2-dimethyl-6-nitro-1H-benzoimidazole 
• 41939-61-1 N₁-methyl-4-nitrobenzene-1,2-diamine 
• 45869-07-6 N¹,N¹-dimethyl-benzene-1,2,4-triyltriamine 
• 108-24-7 acetic anhydride 

Downstream Products

• 444731-57-1 3-({4-[(1,2-dimethyl-1H-benzimidazol-5-yl)(methyl)amino]pyrimidin-2-yl}amino)benzenesulfonamide 
• 1352942-35-8 1,2-dimethyl-5-(phthaloyl-L-phenylalanyl)-aminobenzimidazole 
• 1352942-41-6 1,2-dimethyl-5-(L-phenylalanyl)-amino benzimidazole 
• 920978-78-5 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-trifluoromethyl-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[3,2-b]pyridine-2-carboxamide 
• 920978-62-7 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-phenyl-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-c]pyridine-2-carboxamide 
• 920978-71-8 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-trifluoromethyl-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxamide 
• 920978-58-1 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-chloro-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-c]pyridine-2-carboxamide 
• 920978-88-7 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-c]pyridine-2-carboxamide 
• 686747-26-2 5-amino-4-chloro-1,2-dimethylbenzimidazole 
• 17681-45-7 5-Amino-1,2-dimethylimidazo<5,4-g>benzothiazole 

Relevant articles and documents

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Crystal form of pyrimidine derivative

The invention relates to a pyrimidine derivative crystal form, in particular to a crystal form of a compound of formula (I) as shown in the specification, and a medicine composition of the crystal form, further to application of the crystal form or the me

New antibacterial diazotized derivatives of 5-amino azaheterocycles

Six new diazotized derivatives of pharmacologically important azaheterocycles (2a-d, 4a-b) were prepared from their corresponding 5-amino benzimidazoles (1a-d) and benzimidazolones (3a-b). All new compounds have been characterized on the basis of their IR, NMR and Mass spectral data. Antibacterial activity of these compounds is also been reported.